Deer antler velvet and sexual function: the placebo-controlled trial found no benefit
A 12-week blinded trial found no sexual-function or hormone advantage from deer antler velvet in healthy middle-aged men.

The only direct placebo-controlled study found no sexual or hormone benefit from deer antler velvet in healthy men.
Traditional reputation is not a trial result
Deer antler velvet is sold for vitality, libido, testosterone, recovery, and sexual performance. These are different outcomes, and historical use cannot show whether a modern capsule changes any of them. A responsible evaluation needs a defined product, comparison group, validated outcomes, and sufficient follow-up.
Composition also varies by species, harvest stage, processing, and extraction. Powder, spray, and liquid extracts should not be treated as one uniform intervention. Even a favorable study of one preparation would not automatically establish the effect of every velvet product.

The blinded trial was small but direct
A 12-week double-blind placebo-controlled study randomly assigned 32 men ages 45 to 65 and assessed sexual function in the men and their partners. Investigators also measured sex-related hormones before and after treatment. This design addressed the advertised outcome more directly than animal studies or testimonials.
The groups did not differ significantly in men's sexual behavior, partner-reported sexual function, or hormone changes. The sample was small and involved healthy volunteers, so it cannot exclude a subtle effect in every population. It does directly challenge a broad claim that velvet reliably enhances sexual function in healthy middle-aged men.
A null result should not be rewritten as underdosing
When a trial is negative, marketers may argue that a different dose, extract, or user would respond. Those are hypotheses for new research, not evidence of benefit. The burden is on a new controlled trial to identify the preparation and population that outperform placebo.
It is also misleading to highlight individual participants who improved without showing that improvement exceeded placebo. Sexual-function scores can change with expectation, relationship factors, health, and time. Randomization is designed to separate those influences from the product effect.

Hormone claims failed the same test
The trial found no significant sex-hormone advantage, so it cannot support a testosterone-booster claim. Hormone measurements and sexual experiences are separate outcomes: even if one changed, the other would need direct evidence. Product advertising often bundles them to make a single study sound broader than it is.
Men concerned about low testosterone need symptoms interpreted with properly timed laboratory measurements, often repeated. A response to a velvet product is not diagnostic. Healthy-volunteer research also cannot establish treatment of clinically confirmed hypogonadism.
Product origin adds nonclinical questions
Consumers may care about animal sourcing, manufacturing, contamination testing, and restrictions in organized sport. Those quality and ethical questions are separate from clinical efficacy. A certificate of analysis does not turn a negative sexual-function trial into a positive one.
This guide does not recommend deer antler velvet for sexual enhancement. The direct human study found no advantage over placebo. Until larger, product-matched trials replicate a meaningful benefit, labels should not present tradition, growth-factor language, or athletic imagery as proof of improved erections, desire, or hormones.
The volunteers were healthy men, not patients selected for erectile dysfunction, infertility, or confirmed hormone deficiency. That limits both directions of inference: the null result cannot exclude every hypothetical subgroup, but marketers cannot assume a subgroup benefit without testing it. A new population claim needs a randomized trial in that population.
The partner questionnaires added another perspective, yet the small sample still creates wide uncertainty. Future research should characterize the product, prespecify responder thresholds, report every sexual-function domain, and disclose missing data and commercial relationships. Independent replication would matter more than repeating the same traditional rationale.
Growth-factor language is another unsupported bridge. Detecting or discussing a compound in antler tissue does not establish oral absorption, a meaningful human hormone change, or improved sexual function. Consumers should ask for direct clinical outcomes from the finished product rather than accept assumptions from tissue composition to performance.
Quality documentation should identify animal species, source, processing, batch identity, contaminants, and the exact material used in any cited trial. Those records can improve traceability but cannot establish efficacy. Sport participants also should check governing-body rules and contamination risks independently. A product can be legally sold and still lack evidence for libido, erections, hormones, or recovery.
Sources & further reading
This article provides educational information. Ask a qualified clinician or pharmacist about your symptoms, medical conditions, medicines and supplement interactions.